Successful Xenograft of Endoscopic Ultrasound-Guided Fine-Needle Aspiration Specimen from Human Extrahepatic Cholangiocarcinoma into an Immunodeficient Mouse

Patient-derived tumor xenograft is the transfer of primary human tumors directly into an immunodeficient mouse. Patient-derived tumor xenograft plays an important role in the development and evaluation of new chemotherapeutic agents. We succeeded in generating a patient-derived tumor xenograft of a biliary tumor obtained by endoscopic ultrasound-guided fine-needle aspiration from a patient who had an inoperable extrahepatic cholangiocarcinoma. This patient-derived tumor xenograft will be a promising tool for individualized cancer therapy and can be used in developing new chemotherapeutic agents for the treatment of biliary cancer in the future.     

Synchronous Pancreatic Ductal Adenocarcinomas Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Biopsy

Cases of pancreatic ductal adenocarcinoma with multiple masses accompanying underlying pancreatic diseases, such as intraductal papillary mucinous neoplasm, have been reported. However, synchronous invasion without underlying pancreatic disease is very rare. A 61-year-old female with abdominal discomfort and jaundice was admitted to our hospital. Abdominal computed tomography (CT) revealed cancer of the pancreatic head with direct invasion of the duodenal loop and common bile duct. However, positron emission tomography-CT showed an increased standardized uptake value (SUV) in the pancreatic head and tail. We performed endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) for the histopathologic diagnosis of the pancreatic head and the evaluation of the increased SUV in the tail portion of the pancreas, as the characteristics of these lesions could affect the extent of surgery. As a result, pancreatic ductal adenocarcinomas were confirmed by both cytologic and histologic analyses. In addition, immunohistochemical analysis of the biopsy specimens was positive for carcinoembryonic antigen and p53 in both masses. The two masses were ultimately diagnosed as pancreatic ductal adenocarcinoma, stage IIB, based on EUS-FNB and imaging studies. In conclusion, the entire pancreas must be evaluated in a patient with a pancreatic mass to detect the rare but possible presence of synchronous pancreatic ductal adenocarcinoma. Additionally, EUS-FNB can provide pathologic confirmation in a single procedure.     

Clinical Impact of Endoscopic Ultrasound and Endoscopic Ultrasound-Guided Fine-Needle Aspiration in the Management of Rectal Carcinoma

PURPOSE: There is scant data about the clinical impact of endoscopic ultrasound-guided fine-needle aspiration in rectal carcinoma. This study was designed to determine the impact of endoscopic ultrasound-guided fine-needle aspiration on the staging and management of rectal carcinoma and to compare the staging accuracy of computed tomography scan, endoscopic ultrasound, and endoscopic ultrasound-guided fine-needle aspiration. METHODS: The records of 60 consecutive patients diagnosed with rectal carcinoma referred for endoscopic ultrasound staging were reviewed. Computed tomography scans, endoscopic ultrasound imaging, endoscopic ultrasound-guided fine-needle aspiration staging, surgical pathology, and subsequent treatment were compared. RESULTS: Of 48 patients who underwent computed tomography scan imaging, the additional information provided by endoscopic ultrasound changed management in 38 percent of patients. Sixteen patients identified as having nonjuxtatumoral lymph nodes underwent fine-needle aspiration and the additional information obtained changed therapy in three (19 percent) of these patients. All five cases of recurrent rectal carcinoma were correctly diagnosed by fine-needle aspiration. Tumor staging accuracy was 45 percent (computed tomography) and 89 percent (endoscopic ultrasound; P < 0.0001); nodal staging accuracy was 68 percent (computed tomography), 85 percent (endoscopic ultrasound), and 92 percent (endoscopic ultrasound-guided fine-needle aspiration; P = not significant). CONCLUSIONS: Endoscopic ultrasound imaging was better than computed tomography scanning at overall tumor staging, whereas endoscopic ultrasound-guided fine-needle aspiration demonstrated a trend toward more accurate nodal staging. Preoperative staging with endoscopic ultrasound resulted in a change of management in 38 percent of patients. The addition of fine-needle aspiration changed the management in 19 percent of those who underwent nonjuxtatumoral lymph node sampling. Endoscopic ultrasound-guided fine-needle aspiration accurately diagnosed 100 percent of those with recurrent rectal carcinoma. Clearly, endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration are important for the staging and management of rectal carcinoma and for detecting disease recurrence.Presented at the EUS 13th International Symposium on Endoscopic Ultrasound, New York, New York, October 4 to 6, 2002     

Histology Combined with Cytology by Endoscopic Ultrasound-Guided Fine Needle Aspiration for the Diagnosis of Solid Pancreatic Mass and Intra-Abdominal Lymphadenopathy

Background/Aims

Small core biopsy samples can occasionally be obtained with conventional endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA). Although most studies have focused on the cytological analysis of specimens, data regarding histological assessment is scarce. The aim of this study was to determine whether core biopsies by conventional EUS-FNA could increase the accuracy of EUS-guided sampling when combined with cytology in the absence of an on-site cytopathologist.

Methods

In the 95 consecutive patients (98 lesions) undergoing EUS-FNA of solid pancreatic masses and intra-abdominal lymphadenopathy, tissue coils from the needle were harvested for histology, and residual tissue was examined by cytology.

Results

Adequate samples were obtained by EUS-FNA cytology, histology, and combined cytology-histology in 91.8%, 65.3%, and 94.8% of patients, respectively. From the pancreas (n=67), adequate samples for histology were obtained by EUS-FNA in 68.7% of cases, compared with 58.0% from non-pancreatic cases (n=31), respectively (p>0.05). The overall sensitivity and accuracy of EUS-FNA was 78.0% and 81.6% for cytology alone, 63.4% and 69.4% for histology alone, and 84.1% and 86.7% for combined cytology-histology, respectively.

Conclusions

Combined cytology and histology analysis for diagnosing pancreatic masses and intra-abdominal lymphadenopathy may increase the diagnostic yield of conventional EUS-FNA without on-site cytology.     

Severe Bleeding and Perforation Are Rare Complications of Endoscopic Ultrasound-Guided Fine Needle Aspiration for Pancreatic Masses: An Analysis of 3,090 Patients from 212 Hospitals

Background/Aims

Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is useful for the pathological diagnosis of pancreatic masses, but patients are susceptible to severe bleeding and perforation. Because the incidence and severity of these complications have not been fully evaluated.

Methods

We aimed to evaluate severe bleeding and perforation after EUS-FNA for pancreatic masses using large-scale data derived from a Japanese nationwide administrative database.

Results

In total, 3,090 consecutive patients from 212 low- to high-volume hospitals were analyzed. Severe bleeding requiring transfusion or endoscopic treatment occurred in seven patients (0.23%), and no perforation was observed. No patient mortality was recorded within 30 days of EUS-FNA. The rate of severe bleeding in low-volume hospitals was significantly higher than that in medium- and high-volume hospitals (0.48% vs 0.10%, p=0.045).

Conclusions

Severe bleeding and perforation following EUS-FNA for pancreatic masses are rare, and the procedure is safe.     

超声内镜引导细针穿刺抽吸术在常规内镜活检诊断不明确 的胃肠道病变中的应用价值

目的 评价超声内镜引导细针穿刺抽吸术（EUS-FNA）在常规内镜活检诊断不明确的胃肠道病变中的应用价值。 方法 回顾性分析65例常规内镜活检诊断不明确的胃肠道病变且在我院行EUS-FNA的患者的诊断结果和随访情况,以手术病理和随访结果为最终诊断,评估EUS-FNA对此类病变的诊断价值。结果 本研究中男性患者41例,女性24例,中位年龄60岁。普通内镜下以弥漫浸润型病变最为多见（56.9%）,其次为黏膜下隆起型病变（21.7%）。54例（83.1%）患者诊断为肿瘤性病变,非肿瘤性病变11例（83.1%）。EUS-FNA总的诊断敏感度、特异度及准确性为76.8%（95%CI: 65.7%-87.8%）、100%（95%CI: 66.4%-100%）、及80.0%（95%CI: 70.3%-89.7%）。亚组分析显示EUS-FNA在弥漫浸润型病变中的诊断敏感度、特异度及准确性分别为70.6%（95%CI: 55.3%-85.9%）、100%（95%CI: 29.2%-100%）及73.0%（95%CI: 58.7%-87.3%）;在黏膜下隆起型病变中的诊断敏感度、特异度及准确性分别为68.8%（95%CI: 46.0%-91.5%）、100%（95%CI: 2.5%-100%）及70.6%（95%CI: 44.0%-89.7%）。结论 EUS-FNA对常规内镜活检诊断不明确的胃肠道病变具有中等强度的诊断价值,可作为此类病变在常规内镜活检无法确诊后的备选方案,但仍需结合其他手段或技术改进以进一步提高EUS-FNA的诊断效能。     

内镜超声引导下穿刺活检术在胰腺囊性病变中的 诊断价值

胰腺囊性病变同时包含良性和恶性,性质不同,预后截然不同。内镜超声引导下细针活检术(endoscopic ultrasound-guided fine needle biopsy,EUS-FNB)因其能够直接获取目标病变的囊液、细胞或组织辅助诊断而倍受青睐。本文对EUS-FNB在胰腺囊性病变诊断中的应用做一综述,大部分研究结果认为EUS-FNB获取病变组织标本进行诊断的能力优于内镜超声引导下细针抽吸术,而新近出现的内镜超声引导下小活检钳活检术亦被证实在病变组织标本及诊断价值方面有其独特的优势。     

Role of endoscopic ultrasound in pediatric patients: A single tertiary center experience and review of the literature

BACKGROUND Although endoscopic ultrasound(EUS) is now widely available and has an established role in adults, the utility of EUS and EUS-guided fine needle aspiration(EUS-FNA) in pediatrics is insufficiently described compared to adults and is supported by only a few studies.AIM To report the experience of a single tertiary center in the use of EUS and EUS-FNA in a pediatric population and to further assess its safety, feasibility, and clinical impact on management.METHODS A retrospective study of 13 children(aged 18 years or younger) identified from our medical database was conducted. A retrospective review of demographic data, procedure indications, EUS findings, and the clinical impact of EUS on the subsequent management of these patients was performed.RESULTS During the 4-year study period, a total of 13(1.7%) pediatric EUS examinations out of 749 EUS procedures were performed in our unit. The mean age of these 8 females and 5 males was 15.6 years(range: 6-18). Six of the 13 EUS examinations were pancreatobiliary(46.1%), followed by mediastinal 2/13(15.4%), peri-gastric 2/13(15.4%), abdominal lymphadenopathy 1/13(7.7%), tracheal 1/13(7.7%) and rectal 1/13(7.7%). Overall, EUS-FNA was performed in 7 patients(53.8%) with a diagnostic yield of 100%. The EUS results had a significant impact on clinical care in 10/13(77%) cases. No complications occurred in these patients during or after any of the procedures.CONCLUSION EUS and EUS-FNA in the pediatric population are safe, feasible, and have a significant clinical impact on the subsequent management; thus avoiding invasive and unnecessary procedures.     

Endoscopic ultrasound guided fine needle aspiration for the diagnosis of intra-abdominal lymphadenopathy: a systematic review and meta-analysis

Abstract

Background: It is difficult to diagnose the cause of abdominal lymphadenopathy without determining the primary lesions. With the advent of curved ultrasound endoscopy, EUS-FNA can sample lymph nodes safely, accurately and conveniently. Due to the lack of formal quantitative and comprehensive literature review to determine the diagnostic value of EUS-FNA in the diagnosis of enlarged intra-abdominal lymph nodes of unknown origin, we conducted this study to systematically evaluate the diagnostic accuracy of EUS-FNA in the enlarged intra-abdominal lymph nodes.

Methods: We performed a systematic review and meta-analysis to evaluate the accuracy of EUS-FNA for the diagnosis of intra-abdominal lymphadenopathy. We searched PubMed, Embase, and Cochrane Library to collect related studies and diagnostic performance data. We used a random-effects model to estimate the pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio and diagnostic odds ratio (DOR). Heterogeneity was assessed by subgroup and meta-regression analysis.

Results: Twelve eligible studies involved 774 patients were identified. The pooled sensitivity and specificity of all studies is 94% (95% CI: 91% to 96%) and 98% (95% CI: 96% to 99%), respectively. The pooled positive and negative likelihood ratios are 17.44 (95% CI, 6.50 to 46.79) and 0.09 (95% CI: 0.06 to 0.14). The pooled DOR is 277.82 (95% CI, 97.65 to 790.46).

Conclusions: EUS-FNA is a safe and feasible technique with high sensitivity and specificity for the diagnosis of abdominal lymph node enlargement. Considering the limitations and heterogeneity, high-quality studies are needed to further explore the diagnostic value of EUS-FNA.     

Multicenter prospective study of the efficacy of stereomicroscopic on-site evaluation in endoscopic ultrasound-guided tissue acquisition in patients with pancreatic cancer

ObjectiveIn sample isolation processing by stereomicroscopy (SIPS), a technique used to assess the quality of specimens collected during endoscopic ultrasound (EUS)-guided tissue acquisition (EUS-TA), the cutoff value of stereomicroscopically visible white core (SVWC) (≥11 mm) indicates high diagnostic sensitivity. However, the procedure of SIPS is complicated and time-consuming. Therefore, we devised the stereomicroscopic on-site evaluation (SOSE), a new rapid assessment method that is simpler than SIPS and only determines if the SVWC cutoff value is attained. We aimed to examine the usefulness of SOSE in a multicenter, prospective setting.MethodsSeventy patients from multiple institutions with solid pancreatic masses suspected to be pancreatic cancer were included. EUS-TA was performed using a 22-gauge Franseen needle. SVWCs were measured on-site using stereomicroscopy. The primary outcome was the sensitivity of SVWC cutoff value in EUS-TA with SOSE.ResultsThe total number of punctures was 214 and SOSE was performed on 150 punctures. The SVWC cutoff value collection rate was 100% per lesion, with 80% in the first pass, 79% in the second pass, and 78% per puncture in all passes. The median time taken to determine the SVWC cutoff value for SOSE was 47 s. The sensitivity of the SVWC cutoff value was 93.2% for histology and 96.6% for cytology + histology. The per-lesion accuracy of pathological diagnosis reached the highest level (98.6%) at the second puncture.ConclusionsSOSE showed high diagnostic sensitivity and may be a new rapid assessment method for the diagnosis of malignant pancreatic cancer using EUS-TA.     

Endoscopic ultrasound and paracentesis in the evaluation of small volume ascites in patients with intra-abdominal malignancies

The evaluation of ascites in patients with known or suspected malignancy is a critical aspect of preoperative staging.Endoscopic evaluation by ultrasound of low volume ascites and sampling of the ascitic fluid by endoscopic ultrasound guided paracentesis(EUS-P)is both a sensitive and specific modality for the determination of peritoneal implants,which is not only an important prognostic indicator but a crucial factor in determining treatment strategy.It is common practice to utilize EUS for gastrointestinal malignancies such as pancreatic or gastric masses,with the performance of paracentesis during the same procedure for the purpose of imaging the abnormality and possibly performing fine needle aspiration for biopsy of the neoplasm itself.However,given the ability of EUS-P to adequately sample even minimal ascites,detecting much smaller volumes than traditional computed tomography or magnetic resonance imaging,EUS-P may be a useful modality for the standard metastatic workup of any newly diagnosed or suspected malignancy.In this"Field of Vision"commentary,we discuss the role of EUS-P,including the article by Suzuki et al reporting their experience with EUS-P using an automated spring-loaded needle device.We also review the utility of EUS-P for non-gastrointestinal malignancies,such as ovarian cancer,which has a high incidence of malignant ascites.     

Comparing Needles and Methods of Endoscopic Ultrasound–Guided Fine-Needle Biopsy to Optimize Specimen Quality and Diagnostic Accuracy for Patients With Pancreatic Masses in a Randomized Trial

1. Download : Download high-res image (107KB)
2. Download : Download full-size image

     

Endoscopic ultrasound-guided fine needle aspiration in the differentiation of type 1 and type 2 autoimmune pancreatitis

AIM: To investigate the usefulness of endoscopic ultra-sound-guided fine needle aspiration (EUS-FNA) in the differentiation of autoimmune pancreatitis (AIP).METHODS: We retrospectively reviewed 47 of 56 AIP patients who underwent EUS-FNA and met the Asian diagnostic criteria. On 47 EUS-FNA specimens, we evaluated the presence of adequate material and characteristic features of lymphoplasmacytic sclerosing pancreatitis (LPSP) and idiopathic duct-centric pancreatitis (IDCP) mentioned in the International Consensus Diagnostic Criteria and examined if these findings make a contribution to the differential diagnosis of type 1 and type 2 AIP. A disposable 22-gauge needle was used for EUS-FNA.RESULTS: Adequate specimens including pancreatic tissue for differentiating AIP from cancer were obtained from 43 of 47 patients who underwent EUS-FNA. EUS-FNA was performed from the pancreatic head in 21 cases, which is known to be technically difficult when performed by core biopsy; there was no significant difference in the results compared with pancreatic body-tail. Nine of 47 patients met level 1 findings of LPSP and 5 patients met level 2 findings of LPSP. No one met level 1 findings of IDCP, but 3 patients met level 2 findings of IDCP. Of 10 seronegative cases, 2 cases were diagnosed with “definitive type 1 AIP”, and 3 cases were diagnosed with “probable type 2 AIP” when considering both the level 2 histological findings and response to steroids.CONCLUSION: EUS-FNA is useful in the differentiation of type 1 and type 2 AIP, particularly in seronegative cases.     

Similarities and differences in guidelines for the management of pancreatic cysts

Accurate diagnosis of Pancreatic cysts(PC) is key in the management. The knowledge of indications for surgery, the role of endoscopic ultrasound-guided fine needle aspiration, cyst fluid analysis, imaging, and surveillance of PC are all important in the diagnosis and management of PC. Currently, there are many guidelines for the management of PC. The optimal use of these guidelines with a patient-centered approach helps diagnose early cancer and prevent the spread of cancer.     

Histological diagnosis and grading of pancreatic neuroendocrine tumor by endoscopic ultrasound-guided fine needle biopsy using a 25-gauge needle with a core trap: A multicenter prospective trial

ObjectivesPreoperative grading of pancreatic neuroendocrine tumors (PanNET) is challenging. The aim of this study was to prospectively evaluate the use of a 25-gauge needle with a core trap for diagnosis and grading of PanNET.MethodsThis multicenter prospective trial was registered with the University Hospital Medical Information Network (UMIN000021409). Consecutive patients with suspected PanNET between June 2016 and November 2017 were enrolled. All patients underwent endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) using a 25-gauge needle with a core trap. Samples obtained after the first needle pass were used for central pathological review. EUS-FNB was evaluated in terms of (i) technical success rate, (ii) adequacy for histological evaluation, (iii) complication rate during the procedure, and (iv) concordance between PanNET grading on EUS-FNB and that after analysis of the resected tumor.ResultsFifty-two patients were enrolled. Of the 36/52 patients who underwent surgical resection, 31 were finally diagnosed with PanNET and were eligible for analysis. The technical success rate of EUS-FNB was 100%. The rate of adequacy for histological evaluation was 90.3%. There were no complications related to EUS-FNB. The concordance rate between PanNET grading on EUS-FNB and that after analysis of the resected tumor was 82.6% (95% confidence interval = 61.22–95.05, P = 0.579).ConclusionsEUS-FNB using a 25-gauge needle with a core trap is feasible, providing histological samples are of sufficient quality for diagnosis and grading of PanNET.